Candidate antibody reference reagents for Chlamydia trachomatis serology
Authors:
- 24 September 2024
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 534, 113761
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Advances in vaccine development for Chlamydia trachomatisPathogens and Disease, 2024
- Availability and use of Standards in vaccine developmentnpj Vaccines, 2023
- Monitoring transmission intensity of trachoma with serologyNature Communications, 2023
- Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK BiobankNature Communications, 2022
- Call for consensus in Chlamydia trachomatis nomenclature: moving from biovars, serovars, and serotypes to genovariants and genotypesClinical Microbiology and Infection, 2022
- Chlamydia trachomatis: Cell biology, immunology and vaccinationVaccine, 2021
- Seroprevalence of Chlamydia trachomatis Among Female Adults in the United States: The National Health and Nutrition Examination SurveysClinical Infectious Diseases, 2020
- Advancing the public health applications of Chlamydia trachomatis serologyThe Lancet Infectious Diseases, 2018
- Chlamydia cell biology and pathogenesisNature Reviews Microbiology, 2016
- Structure of the Chlamydia trachomatis Immunodominant Antigen Pgp3Journal of Biological Chemistry, 2013